SIOUX FALLS, SD - Federal health inspectors cited Dow Rummel Village, a senior living community in Sioux Falls, South Dakota, after a complaint investigation revealed that a significant medication error resulted in actual harm to a resident. The investigation, conducted on November 13, 2025, found the facility deficient under federal regulatory tag F0760, which requires that nursing home residents remain free from significant medication errors.
Complaint Investigation Reveals Pharmacy Service Failure
The citation against Dow Rummel Village stemmed from a complaint-driven investigation, meaning an individual — whether a resident, family member, or staff member — filed a formal concern that prompted federal regulators to examine conditions at the facility. Unlike routine annual surveys, complaint investigations are triggered by specific allegations of harm or regulatory noncompliance, lending additional gravity to the findings.
Inspectors determined that the facility failed to meet the federal standard requiring that residents are free from significant medication errors. This standard, codified under the pharmacy services section of federal nursing home regulations, places responsibility on facilities to maintain rigorous medication management systems that prevent errors capable of causing harm.
The deficiency was classified at Scope/Severity Level G, which in the federal regulatory framework indicates an isolated incident that caused actual harm but did not rise to the level of immediate jeopardy. While "isolated" means the error did not appear to be a widespread or systemic pattern across the facility, the "actual harm" designation confirms that a resident experienced real, documented negative consequences as a direct result of the medication error.
Understanding the Severity Classification
The federal government uses a grid system to classify nursing home deficiencies based on two factors: scope (how widespread the problem is) and severity (how much harm resulted or could result). The scale ranges from Level A, representing an isolated deficiency with potential for minimal harm, to Level L, indicating widespread immediate jeopardy to resident health or safety.
Level G falls in the middle-upper range of this scale, and its designation carries significant weight. At this level, inspectors have confirmed that the deficiency moved beyond the realm of potential risk and into documented, real-world consequences for a resident. Facilities receiving Level G citations face mandatory corrective action plans and increased regulatory scrutiny.
For context, the majority of nursing home deficiencies cited nationwide fall in the lower severity categories — typically Levels D through F — where potential for harm exists but no actual harm has been documented. When a citation reaches Level G or above, it signals that protective systems within the facility failed to the point where a resident was tangibly affected.
The Medical Significance of Medication Errors
Medication errors in nursing home settings represent one of the most closely monitored areas of patient safety in long-term care. Residents of skilled nursing facilities are among the most medically vulnerable populations in the healthcare system, often managing multiple chronic conditions simultaneously with complex medication regimens.
The average nursing home resident takes between seven and ten medications daily, according to published research on polypharmacy in long-term care. This high medication burden creates numerous opportunities for error at every stage of the medication management process — from prescribing and transcribing to dispensing, administering, and monitoring.
Medication errors can take many forms in a nursing home environment. They include but are not limited to:
- Wrong medication administered to a resident - Incorrect dosage — either too much or too little of a prescribed drug - Wrong time of administration, which can affect drug efficacy and interactions - Missed doses, potentially allowing a medical condition to worsen - Administration to the wrong resident, a particularly dangerous scenario - Failure to monitor for side effects or adverse reactions after administration - Drug interactions that were not properly screened or managed
Each of these error types carries distinct medical risks. An overdose of blood-thinning medication, for example, can lead to internal bleeding. A missed dose of an antibiotic can allow an infection to progress. Administering a medication intended for one resident to another can trigger allergic reactions or dangerous drug interactions.
Why Elderly Residents Face Greater Risk
Older adults are disproportionately vulnerable to the effects of medication errors due to age-related physiological changes. Kidney and liver function, which are responsible for processing and eliminating drugs from the body, decline naturally with age. This means medications may remain in an elderly person's system longer than expected, increasing the risk of toxicity even at standard doses.
Additionally, many nursing home residents have reduced cognitive function, meaning they may not be able to identify or report symptoms of a medication error themselves. This places an even greater responsibility on nursing staff and pharmacy services to maintain accurate medication administration records and conduct appropriate monitoring.
Body composition changes in elderly individuals — including decreased water content and increased body fat percentage — also alter how drugs are distributed throughout the body. These pharmacokinetic changes mean that the margin for error in medication management is significantly narrower for nursing home residents than for younger, healthier populations.
Federal Standards for Medication Management
Under federal regulations governing Medicare- and Medicaid-certified nursing facilities, homes are required to maintain comprehensive pharmacy services that ensure the accurate acquiring, receiving, dispensing, and administering of all drugs and biologicals. The regulatory tag F0760, under which Dow Rummel Village was cited, specifically addresses the obligation to keep residents free from significant medication errors.
A "significant" medication error, as defined by federal guidelines, is one that causes or has the potential to cause the resident discomfort, jeopardize health and safety, or result in clinically significant consequences. This is distinct from minor documentation discrepancies or technical errors that do not affect resident outcomes.
Facilities are expected to have multiple layers of safeguards in place to prevent medication errors. These typically include:
- Licensed pharmacist review of all medication orders - Medication administration records (MARs) that are maintained in real time - Double-check systems for high-risk medications - Staff training programs on proper medication administration techniques - Incident reporting protocols that capture and analyze errors when they occur - Regular medication regimen reviews conducted by a licensed pharmacist
When a medication error results in actual harm, it indicates that one or more of these safeguards failed. Federal inspectors examine not only the error itself but the systems and processes that should have prevented it.
Corrective Action and Facility Response
Following the citation, Dow Rummel Village was required to submit a plan of correction to address the identified deficiency. According to regulatory records, the facility reported correction of the deficiency as of December 14, 2025, approximately one month after the inspection finding.
A plan of correction typically requires the facility to outline specific steps taken to remedy the immediate harm, identify the root cause of the deficiency, implement systemic changes to prevent recurrence, and establish monitoring mechanisms to verify ongoing compliance. State survey agencies may conduct follow-up visits to confirm that corrective measures have been properly implemented.
The status of "Deficient, Provider has date of correction" indicates that while the facility has self-reported its corrective actions, regulatory verification of those corrections may still be pending or subject to future review during subsequent survey visits.
Industry Context and Broader Implications
Medication errors remain a persistent challenge across the long-term care industry nationally. Published studies have estimated that medication-related adverse events occur in nursing homes at rates that make pharmacy services one of the most frequently cited areas of deficiency during federal inspections.
The Centers for Medicare & Medicaid Services (CMS), which oversees the federal nursing home inspection program, has identified medication management as a priority area for quality improvement in long-term care settings. Facilities that receive citations for medication errors resulting in actual harm face potential consequences including increased survey frequency, mandatory staff retraining, and in severe or repeated cases, financial penalties.
For families with loved ones at Dow Rummel Village or any skilled nursing facility, medication safety experts recommend maintaining an updated list of all prescribed medications, asking questions during care conferences about how medications are managed, and promptly reporting any observed changes in a resident's condition that could indicate a medication-related issue.
How to Access the Full Inspection Report
The complete inspection findings for Dow Rummel Village, including detailed narratives describing the specific circumstances of the medication error, are available through the Centers for Medicare & Medicaid Services' Care Compare website. These public records provide additional context about the deficiency, including observations made by inspectors, interviews conducted during the investigation, and specific regulatory requirements that were not met.
Residents and family members also have the right to request inspection reports directly from the facility, which is required under federal law to make its most recent survey results available for public review.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Dow Rummel Village from 2025-11-13 including all violations, facility responses, and corrective action plans.
💬 Join the Discussion
Comments are moderated. Please keep discussions respectful and relevant to nursing home care quality.